NCT05371873 A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer Status UNKNOWN Phase N/A
NCT05363722 A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1
NCT05359939 A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT05359861 Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT05355662 Prognosis Analysis of Elderly Donor Liver in Liver Transplantation Status COMPLETED Phase N/A
NCT05352646 NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection Status UNKNOWN Phase PHASE1
NCT05349331 Watch and Wait and Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT05344924 TACE Combined With Penpulimab and Anlotinib for Advanced HCC Status UNKNOWN Phase PHASE2/PHASE3
NCT05342350 International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy Status TERMINATED Phase N/A
NCT05339581 IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation Status UNKNOWN Phase NA
NCT05339321 Autologous HBV-specific T Cell Receptor Engineered T Cells (TCR-T) in Patients With HBV-related Advanced HCC Status UNKNOWN Phase PHASE1
NCT05332821 TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC Status COMPLETED Phase N/A
NCT05332496 TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC Status COMPLETED Phase N/A
NCT05331911 Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors Status RECRUITING Phase PHASE4
NCT05323201 Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT05320692 A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05317819 Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma Status RECRUITING Phase PHASE3
NCT05312216 Durvalumab Plus Lenvatinib as First-line Treatment for Unresectable Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2
NCT05304572 Multi-Detector CT Angiography With 3D Reconstruction Versus Digital Subtraction Angiography Status COMPLETED Phase N/A